Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study

GNbAC1 is a humanized IgG4 monoclonal antibody antagonist of Mulitple Sclerosis Retrovirus Envelope (MSRV-Env), a protein that could play a critical role in multiple sclerosis. This randomized placebo-controlled dose-escalation study evaluated the safety and pharmacokinetics of GNbAC1 in 21 healthy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:MAbs
Autors principals: Curtin, François, Vidal, Virginie, Bernard, Corinne, Kromminga, Arno, Lang, Alois B., Porchet, Hervé
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968100/
https://ncbi.nlm.nih.gov/pubmed/27030142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1168956
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars